Skip to main content
. 2012 Dec 30;2012:512401. doi: 10.1155/2012/512401

Table 2.

Follow-up strategy based on risk groups (adapted from [4]).

Initial estimate of risk of recurrence first 2 years of followup incomplete response
Suppressed Tg Low risk
Q 6 months
Intermediate risk
Q 6 months
High risk
Q 6 months
Stimulated Tg Not required <10 ng/mL >10 ng/mL
Neck ultrasound Q year × 2 Q year × 2 Q year × 2
Diagnostic RAI WBS Not required 1-2 years 1-2 years
Cross-sectional imaging (MRI, CT) Not required Not required If Tg elevated or high clinical suspicion

Secondary risk stratification response to therapy assessment

Ongoing followup Yearly physical examination, yearly suppressed Tg Yearly physical examination, yearly suppressed Tg, stimulated Tg to document undetectable Tg on suppression,
continued observation/assessment of indeterminate structural abnormalities for at least another 2-3 years
Consider additional cross-sectional imaging, possibly FDG PET scan and the need for additional therapy